Crispr Therapeutics shares owned by Bartlett & Co. Wealth Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Bartlett & Co. Wealth Management
from 13F filings
Historical chart of Bartlett & Co. Wealth Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Bartlett & Co. Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Bartlett & Co. Wealth Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $757k | 11k | 68.16 |
| 2023-12-31 | $714k | 11k | 64.30 |
| 2023-09-30 | $504k | 11k | 45.39 |
More positions owned by Bartlett & Co. Wealth Management
View all positions for Bartlett & Co. Wealth Management